The statement goes against a widely cited study which says one in four people with type 1 diabetes ration insulin because of unaffordability. See what else CEO Lars Fruergaard Jørgensen said about the insulin pricing crisis in a recent Stat+ interview.
The hybrid system, which automates basal insulin delivery, was tested in a non-clinical setting in this hotel-based study of children between two years of age and just under six years of age.
A recall has been initiated of certain MiniMed Paradigm pumps and the MiniMed 508 because security researchers have identified potential cybersecurity vulnerabilities. The security flaws have long been known by those who have used the pumps to make DIY artificial pancreas systems.